2 unknown, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Recruiting 1 |
Follow Midazolam: new trials by email Literature Review of Midazolam trials Research Report on Midazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulized Ketamine for the Treatment of Major Depressive Disorder nebulized ketamine, nebulized midazolam - Severe Depression, Moderate Depression | Phase 3 | Recruiting | Theresa Jacob, PhD, MPH | 40 | 2024-10-16 | 2026-04-24 |
| Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. Dexmedetomidine, Midazolam - Dexmedetomidine, Midazolam | Phase 3 | Unknown | King Abdullah International Medical Research Center | 430 | 2022-04-21 | 2023-04-27 |
| Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance Imaging Dexmedetomidine, Midazolam - MRI, Pediatric Sedation | Phase 3 | Unknown | Brugmann University Hospital | 250 | 2022-03-09 | 2022-03-24 |
Depression (1) · Substance Withdrawal Syndrome (1)
Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Substance-Related Disorders (1)
Midazolam (3) · Dexmedetomidine (2) · Ketamine (1)
Brugmann University Hospital (1) · King Abdullah International Medical Research Center (1) · Theresa Jacob, PhD, MPH (1)
Belgium (1) · Saudi Arabia (1) · United States (1)